ADHD, Perimenopause and Menopause: When Hormones Turn Up the Volume on a Late Diagnosis

Why women are increasingly recognising ADHD in midlife, how hormonal changes affect the ADHD brain, and whether HRT and ADHD medication can help.

When your brain doesn't seem to work as it used to

Have you reached your forties or fifties and suddenly feel that your brain isn't working as it used to? Perhaps you're forgetting things, struggling to find words, losing track of conversations or finding it increasingly difficult to concentrate and organise everyday life.

You might describe it as brain fog. You feel mentally slower, more distracted and less capable of managing things that previously seemed straightforward.

It's easy to attribute these changes to menopause, and hormonal changes certainly play a part. But there is another possibility worth considering: could you also have ADHD?

For many women, perimenopause is the point at which previously unrecognised ADHD becomes much more noticeable. They haven't suddenly developed ADHD. Rather, hormonal changes may have made lifelong difficulties harder to manage. Understanding the relationship between ADHD, hormones and menopause is important, particularly when considering treatment options.

Why are women being diagnosed with ADHD in midlife?

ADHD is a neurodevelopmental condition, meaning it begins in childhood, even if it isn't diagnosed until adulthood.

Historically, ADHD has been associated with disruptive or hyperactive behaviour, particularly in boys. Girls and women are more likely to have less obvious symptoms, including inattentiveness, internal restlessness, emotional difficulties and problems with organisation. Many become skilled at masking their difficulties. They may work exceptionally hard, develop perfectionistic tendencies, rely on elaborate routines or become anxious about making mistakes.

They might be highly capable professionally and manage busy family lives, but at considerable personal cost.

For years, these compensatory strategies may work. However, when perimenopause arrives, the additional cognitive and emotional demands can become overwhelming.

This is why some women seek an ADHD assessment in their forties or fifties. They haven't suddenly developed ADHD; their usual coping mechanisms may simply no longer be enough.

What happens to the ADHD brain during menopause?

ADHD is associated with differences in the regulation of neurotransmitters, particularly dopamine and noradrenaline. These are involved in attention, motivation, working memory and executive functioning.

Oestrogen also influences dopamine and other neurotransmitter systems.

During perimenopause, oestrogen levels fluctuate considerably before eventually declining. These changes may affect the brain systems involved in attention, motivation and emotional regulation.

For women with ADHD, this may mean that existing symptoms become more pronounced.

The 2025 systematic review ADHD and Sex Hormones in Females explores the relationship between sex hormones and ADHD, highlighting the potential significance of hormonal changes while recognising that further research is needed.

It is therefore biologically plausible that declining or fluctuating oestrogen can make ADHD symptoms harder to manage, although the precise relationship is not yet fully understood.

For some women, it can feel as though somebody has turned up the volume on difficulties that have always been there.

Brain fog: menopause, ADHD or both?

Brain fog is one of the most frequently reported difficulties during perimenopause and menopause.

It can include:

• Forgetting words or struggling to retrieve information.

• Losing track of conversations.

• Difficulty concentrating or processing information.

• Forgetting appointments or everyday tasks.

• Problems with planning, prioritising and decision-making.

• Feeling mentally slower or easily overwhelmed.

Research confirms that cognitive changes can occur during the menopause transition.

Maki and Jaff (2024), writing in Menopause, discuss the cognitive difficulties experienced by midlife women, including small but reliable declines in objective memory performance.

For women with ADHD, these changes can be particularly challenging.

ADHD already affects executive functioning, including working memory, organisation, planning and task initiation. When menopause introduces additional cognitive difficulties, the combined impact can be substantial.

Imagine a woman who has always relied on lists, reminders and carefully organised routines to manage her ADHD. During perimenopause, she finds that even these strategies are becoming less effective.

She forgets what she was doing, loses track of conversations and struggles to complete tasks that previously felt manageable.

This can be frightening, particularly for women who have always considered themselves intelligent and capable.

However, brain fog doesn't necessarily mean that memory is deteriorating in the way it might with dementia. Sleep disruption, anxiety, hormonal fluctuations and ADHD can all contribute to cognitive difficulties. It is important to consider the whole picture rather than attributing everything to either ADHD or menopause.

Can HRT help?

Hormone replacement therapy (HRT) is primarily used to manage menopause symptoms associated with declining ovarian hormones. For some women, HRT can improve sleep, reduce hot flushes and night sweats, and help with menopause-related mood difficulties.

But could it also help ADHD? There are several possible explanations for why it might.

Improved sleep: Poor sleep can significantly worsen attention, working memory and emotional regulation. If HRT reduces night-time symptoms and improves sleep, some women may find their ADHD easier to manage.

Cognitive functioning: Because oestrogen influences dopamine signalling, there is a plausible biological explanation for why restoring oestrogen levels might help some women with cognitive difficulties.

Emotional wellbeing: Reducing menopause-related anxiety, irritability and low mood may also improve a woman's capacity to manage everyday ADHD challenges.

However, it is important to be realistic. There is currently insufficient evidence to establish that HRT directly treats ADHD or reliably improves its core symptoms.

Its benefits may be indirect, by reducing the additional difficulties that make ADHD harder to manage.

What about ADHD medication?

Some women find that ADHD medication which previously worked well becomes less effective during perimenopause. Others notice increased distractibility, emotional difficulties or changes in medication side effects.

Given the relationship between oestrogen and dopamine, hormonal fluctuations may contribute to these changes. However, sleep problems, anxiety, depression and other menopause symptoms can also affect how well ADHD medication appears to work. It is therefore worth reviewing treatment rather than automatically assuming that a higher medication dose is needed.

Sometimes addressing menopause symptoms may be more helpful than increasing ADHD medication.

Stimulants such as methylphenidate and lisdexamfetamine, and non-stimulants such as atomoxetine, can remain important treatment options. However, medication decisions should always be individualised.

Can HRT and ADHD medication be taken together?

For women experiencing both ADHD and menopause symptoms, this is an important question.

HRT and ADHD medication have different therapeutic purposes and can be prescribed together where clinically appropriate. The 2026 review by Wynchank and Kooij, Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause, explores the potential benefits of considering menopausal hormone therapy alongside ADHD medication.

An important clinical consideration is that a woman whose ADHD medication is working reasonably well may benefit more from treating her menopause symptoms than simply increasing her ADHD medication. This recognises that worsening concentration and brain fog aren't necessarily signs that ADHD medication is no longer effective.

However, research specifically investigating combined HRT and ADHD medication remains limited. We don't yet have sufficient clinical trials to establish the best treatment combinations or predict which women will benefit most. A coordinated approach involving the GP, menopause specialist and ADHD prescriber can help identify the most appropriate treatment.

What should you do if you recognise yourself?

If you've experienced lifelong difficulties with attention, organisation, time management or emotional regulation, but these have become significantly worse during perimenopause, an ADHD assessment may be worth considering. Equally, discuss your menopause symptoms with your GP or an appropriately qualified menopause specialist. It can be helpful to keep a record of changes in concentration, memory, sleep, mood, menstrual cycles and the effectiveness of any existing medication.

Remember that ADHD is a lifelong neurodevelopmental condition, so an assessment should explore childhood experiences as well as current difficulties. Persistent or rapidly worsening memory problems should also be medically assessed rather than automatically attributed to ADHD or menopause.

Neither HRT nor ADHD medication is suitable for everyone, and you should never change medication doses without medical advice.

The emotional impact of a late diagnosis

There is another important aspect of this experience: the emotional impact of discovering you have ADHD later in life.

For many women, diagnosis brings enormous relief. Experiences that previously felt confusing or frustrating suddenly make sense. But there can also be grief and anger.

You may look back at your childhood, education, relationships or working life and wonder how different things might have been if somebody had recognised your difficulties earlier. You may begin to understand why you've worked so hard to appear organised, why everyday tasks have felt exhausting or why you've repeatedly criticised yourself for not managing things as easily as other people.

Psychological therapy can help women understand these experiences, address the impact of years of masking and develop more compassionate ways of managing ADHD. The aim isn't to keep trying harder to fit into expectations that don't work for you. It's to understand your individual needs and find strategies that do.

In conclusion

The relationship between ADHD and menopause is an important and developing area of research.

For women with previously unrecognised ADHD, perimenopause may expose difficulties that have been present throughout their lives. For women already diagnosed, hormonal changes may make existing symptoms harder to manage.

Brain fog is particularly significant because it can reflect several overlapping factors, including ADHD-related executive dysfunction, menopause-related cognitive changes, disrupted sleep and emotional distress.

HRT may help by reducing menopause symptoms and potentially supporting aspects of cognitive functioning. ADHD medication can address ADHD symptoms, and for some women, a combination of the two may offer the most helpful approach.

We still need considerably more research to understand exactly how these treatments interact.

But perhaps the most important message is this: if you're struggling more than you used to, it doesn't mean you're becoming less intelligent, less capable or less competent. There may be very good reasons why life has suddenly become harder. Understanding those reasons is the first step towards finding a way forward.

References

• Wynchank, D. & Kooij, S. (2026). Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause. Drugs & Aging.

• ADHD and Sex Hormones in Females: A Systematic Review (2025).

• Maki, P.M. & Jaff, N.G. (2024). Menopause and brain fog: how to counsel and treat midlife women. Menopause, 31(7), 647–649.

• NICE. Menopause: identification and management (NG23).